Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays, and other kits. The company was founded by David Douglas Cleevely, Anthony Kouzarides, and Jonathan Simon Milner on February 12, 1998 and is headquartered in Cambridge, the United Kingdom.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Abcam market cap is $5.5B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Abcam 52 week high is $22.25 as of November 19, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Abcam 52 week low is $22.25 as of November 19, 2026.
Abcam stock price today is $22.25.
Abcam stock price yesterday was $22.10.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Abcam 50-day moving average is $22.25.